Cellebrite DI (CLBT) EBITDA (2019 - 2025)
Cellebrite DI (CLBT) EBITDA from Dec 31, 2019 to Dec 31, 2025. The TTM Cellebrite DI (CLBT) EBITDA is $78M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Cellebrite DI (CLBT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +16.06% |
| 3 Years | +97.05% |
| 5 Years | +39.00% |
| All Time | +76.84% |
Annual EBITDA change of Cellebrite DI (CLBT)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $78M | +16.06% |
| 2024 | $68M | +56.09% |
| 2023 | $43M | +322.36% |
| 2022 | $10M | -50.84% |
| 2021 | $21M | +37.95% |
| 2020 | $15M | +489.84% |
| 2019 | $2.56M | N/A |
Comparison Cellebrite DI (CLBT) five years EBITDA CAGR with competitors
Cellebrite DI (CLBT) five years EBITDA CAGR is 39.00%.